Steven L. Barriere

Telavancin Versus Vancomycin for the Treatment of Complicated Skin and Skin‐Structure Infections Caused by Gram‐Positive Organisms

Martín E. Stryjewski, Donald R. Graham, Samuel E. Wilson et al. · Clinical Infectious Diseases · 2008 · 289 citations

Pharmacy, Infectious Diseases, Pharmacology +17

Telavancin versus Vancomycin for Hospital-Acquired Pneumonia due to Gram-positive Pathogens

Eric Rubinstein, Tahaniyat Lalani, G. Ralph Corey et al. · Clinical Infectious Diseases · 2010 · 246 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Treatment of hospitalized patients with complicated Gram-positive skin and skin structure infections: two randomized, multicentre studies of quinupristin/dalfopristin versus cefazolin, oxacillin or vancomycin

Ronald Lee Nichols, Donald R. Graham, Steven L. Barriere et al. · Journal of Antimicrobial Chemotherapy · 1999 · 178 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Telavancin Versus Standard Therapy for Treatment of Complicated Skin and Soft-Tissue Infections Due to Gram-Positive Bacteria

Martín E. Stryjewski, W. O'Riordan, William K. Lau et al. · Clinical Infectious Diseases · 2005 · 176 citations · Full text

Pharmacy, Microbiology, Pharmacotherapy +16

Telavancin versus Standard Therapy for Treatment of Complicated Skin and Skin Structure Infections Caused by Gram-Positive Bacteria: FAST 2 Study

Martín E. Stryjewski, Vivian H. Chu, William O’Riordan et al. · Antimicrobial Agents and Chemotherapy · 2006 · 165 citations · Full text

Pharmacy, Infectious Diseases, Microbiology +17